Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
Next Oncology Virginia, Fairfax, Virginia South Korea
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do The Catholic Univ. of Korea St. Vincent's Hospital, Suwon, Gyeonggi-do Chungbuk National University Hospital, Cheongju-si, North Chungcheong Seoul National University Hospital, Seoul Severance Hospital, Yonsei University, Seoul Samsung Medical Center, Seoul Asan Medical Center, University of Ulsan, Seoul